In a message dated 8/19/03 1:05:26 PM Eastern Daylight Time,
[log in to unmask] writes:

> At the same time, a drug company is about to begin advanced testing of a
> shot created to curb jaundice in high-risk newborns by halting their
> bodies' production of bilirubin for about a week. The drug's inventor,
> Rockefeller University's Dr. Attallah Kappas, predicts it could
> dramatically cut the number of babies - roughly 100,000 - who undergo
> expensive, cumbersome light therapy for jaundice.
>

Dear Friends:
       Another chilling example of technology run rampant. How will high risk
be defined? What will the impact be of re-routing a natural body defense
mechanism? What about keeping mothers and babies together for unrestricted
breastfeeding? That is the only evidence-based practice to reduce or prevent jaundice
that I know of.
       warmly,
       Nikki Lee

             ***********************************************

To temporarily stop your subscription: set lactnet nomail
To start it again: set lactnet mail (or digest)
To unsubscribe: unsubscribe lactnet
All commands go to [log in to unmask]

The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(TM)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html